SIM
OREX

Spark Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Spark Investment Management’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-53,460
Closed -$919K – 936
2015
Q4 		$919K Buy
53,460
+38,120
+249% +$909K 0.12% 256
2015
Q3 		$322K Buy
15,340
+7,820
+104% +$268K 0.04% 449
2015
Q2 		$371K Buy
+7,520
New +$450K 0.05% 411

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Spark Investment Management's OREX Position: Q1 2016 in Review

Spark Investment Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2016, closing a stake of 53,460 shares — an estimated $919K sold.

Spark Investment Management first reported a position in OREX in Q2 2015 and held it in 3 quarters. The position peaked at $919K in Q4 2015. 104 funds tracked by Wall St. Rank hold OREX as of Q1 2016.

  • Spark Investment Management reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 53,460 Orexigen Therapeutics, Inc. shares in Q1 2016, an estimated $919K.
  • Spark Investment Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
  • Spark Investment Management's Orexigen Therapeutics, Inc. position peaked at $919K in Q4 2015.
  • 104 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.